Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$5.49M Sell
39,056
-900
-2% -$118K 0.31% 80
2014
Q2
$4.73M Buy
39,956
+5,921
+17% +$685K 0.26% 84
2014
Q1
$4.2M Buy
34,035
+96
+0.3% +$11.6K 0.26% 86
2013
Q4
$3.87M Buy
33,939
+6,725
+25% +$765K 0.26% 95
2013
Q3
$3.05M Buy
27,214
+44
+0.2% +$4.77K 0.24% 90
2013
Q2
$2.68M Buy
+27,170
New +$2.82M 0.21% 106

Other funds holding AMGN

McAdams Wright Ragen's AMGN Position: Q3 2014 in Review

McAdams Wright Ragen reduced its Amgen (AMGN) stake by 2.3% in Q3 2014, selling an estimated $118K and leaving 39,056 shares worth $5.49M. The position accounts for 0.31% of the portfolio, ranked #80.

McAdams Wright Ragen first reported a position in AMGN in Q2 2013 and has held it in 6 quarters since. 1,222 funds tracked by Wall St. Rank hold AMGN as of Q3 2014.

  • McAdams Wright Ragen held 39,056 shares of Amgen worth $5.49M as of Q3 2014.
  • McAdams Wright Ragen sold 900 Amgen shares in Q3 2014, an estimated $118K.
  • Amgen made up 0.31% of McAdams Wright Ragen's portfolio in Q3 2014, its #80 holding.
  • McAdams Wright Ragen first reported a position in Amgen in Q2 2013 and has held it in 6 quarters since.
  • 1,222 funds tracked by Wall St. Rank held Amgen as of Q3 2014.

Based on McAdams Wright Ragen's 13F filing for Q3 2014, filed 14 Nov 2014.